| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2008;39:2219.)
© 2008 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology (C.E., S.R., R.S., F.F.) and the Section of Neuroradiology (C.E., F.T., F.E.), Department of Radiology, Medical University of Graz, Graz; and the Department of Neurology (P.K.), Villach, Austria.
Correspondence to Christian Enzinger, MD, Department of Neurology and Section of Neuroradiology, Medical University of Graz, Auenbruggerplatz 22, A-8036 Graz, Austria. E-mail chris.enzinger{at}meduni-graz.at
| Abstract |
|---|
|
|
|---|
Methods— We retrospectively identified 86 patients hospitalized for TGA (mean±SD age, 65.9±10.9 years; 62% female). Brain MRI at 1.5 T was assessed for DWI lesions exhibiting restricted diffusion (ie, DWI+), white-matter hyperintensities, lacunes, and chronic infarcts (median time lag to clinical onset, 66.6±54.6 hours). Vascular risk factors and findings from duplex sonography, ECG, and echocardiography were recorded. A 1:2 age- and sex-matched sample of 172 elderly subjects (mean±SD age, 65.6±9.3 years; 62% female) free of neuropsychiatric disease served for comparison.
Results— DWI lesions were observed in 10 patients with TGA (11.5%; mean±SD age, 68.3±5.4 years; 8 women). They were all small and located in the mesiotemporal region (9 left hemisphere, 5 right hemisphere). The vascular risk profile of TGA patients and concomitant changes on brain MRI were comparable with those of healthy controls and did not show significant differences between DWI+ and DWI– subjects. A comprehensive diagnostic workup also provided no evidence for a higher rate of cerebrovascular disorder-related abnormalities in either the total group of TGA patients or TGA DWI+ patients.
Conclusions— These findings do not support a cerebrovascular etiology of TGA, even in those individuals showing acute DWI lesions. Other pathophysiologic mechanisms need to be explored.
Key Words: transient global amnesia amnestic syndrome magnetic resonance imaging diffusion-weighted imaging risk factors
| Introduction |
|---|
|
|
|---|
A variety of mechanisms and eliciting events such as paradoxical embolism, vertebral angiography, physical exercise, sexual intercourse, emotional stress, arterial thromboembolism, hyperextension of the neck, psychologic disturbances, migraine, cerebral small-vessel disease, venous ischemia due to Valsalva-like maneuvers and, more recently, jugular vein incompetency, have been implicated in the pathophysiology of TGA. (For reviews, see Sander and Sander,3, Pantoni et al,4 and Quinette et al.5) However, almost 5 decades after Fisher and Adams coined this term,6 consensus on its etiology and pathogenesis is still lacking. Conceptually, cerebral ischemia, epileptic discharge, and migraine constitute the main pathogenic hypotheses.
Diffusion-weighted imaging (DWI) has become a powerful tool in the evaluation of patients with suspected stroke owing to its high sensitivity and specificity, even for small areas of acute ischemia, and thereby DWI often provides important etiologic hints.7,8 Consequently, this method has also been applied to TGA to gain further insights into the pathophysiology of this enigmatic condition.9 Indeed, some authors observed DWI lesions in the mesiotemporal region that were mostly punctuate and showed signal characteristics consistent with focal cerebral ischemia.10–19 This created new arguments for a vascular etiology of TGA. However, a recent careful serial magnetic resonance imaging (MRI) study with a dedicated imaging protocol demonstrated that the temporal dynamics of DWI lesion evolution are distinct from "classic" acute focal cerebral ischemia, and those authors proposed delayed ischemia as a possible underlying mechanism.10 Although clinical follow-up has not shown an increased risk for stroke in the overall group of individuals with TGA,1,20,21 it could be speculated that cerebrovascular disease (CVD) might exist at least in those who show acute DWI lesions in the context of this disorder.5 This would have important implications regarding diagnostic workup and preventive therapeutic measures. At present, however, other evidence for a cerebrovascular disorder has not yet been fully analyzed in DWI+ patients, and conclusions are also limited by a report of this finding from mostly smaller series of patients,12,14–16,22–24 except for a few larger studies with up to 41 patients.10,11,13
We therefore wished to further test the "vascular hypothesis" in a large, unselected cohort of patients hospitalized for TGA by first assessing the frequency of acute DWI+ ischemic lesions in patients with TGA and then comparing the vascular risk factor profile and other evidence for a cerebrovascular disorder between TGA patients with and without DWI lesions, also in relation to a cohort of sex- and age-matched population-based normal controls.
| Subjects and Methods |
|---|
|
|
|---|
|
Apart from a careful neurologic examination and medical history, patients underwent repeated blood pressure measurements (n=86), ECGs (n=86), transthoracic echocardiography (n=44), duplex sonography of the extracranial cerebral arteries (n=86), electroencephalography (EEG; n=83), chest x-ray (n=86), and a routine laboratory workup including measurements of cholesterol, triglycerides, and fibrinogen (n=86). EEG findings were mostly normal (n=57, 66.3%) or nonspecific (n=11, 12.8%). Regional slowing of electrical activity was observed in 13 patients (15.1%). Only 2 subjects in the TGA group demonstrated EEG signs compatible with epileptogenic foci (2.3%), and these individuals were DWI–. This distribution of EEG findings (normal, nonspecific regional slowing of electrical activity, and epileptic foci) did not differ significantly between DWI+ and DWI– TGA patients (P=0.065). Vascular risk factors were defined as reported previously.25,26 Four patients had a history of migraine (4.6%), and 3 patients (3.4%) reported that they had experienced symptoms suggestive of a TGA previously (without confirmation by medical doctors).
Healthy Controls
A sample of 172 elderly subjects (mean±SD age, 66±9 years; 107 women and 65 men) was randomly drawn in consecutive order with the investigator unaware of clinical and (if present) MRI findings from the register of the Austrian Stroke Prevention Study (ASPS) to obtain a 1:2 age- and sex-matched control group for comparison of clinical, demographic, and paraclinical variables and risk factors (Table 1). MRI of the brain was performed in subcohorts of the ASPS and was available for 92 individuals with a mean age of 67±9 years. The ASPS is a single-center, prospective, follow-up study on the cerebral effects of vascular and genetic risk factors in the normal elderly population of Graz, Austria. Within the ASPS, individuals are excluded if they have a history of neuropsychiatric disease, including previous cerebrovascular attacks and dementia, or an abnormal neurologic examination determined on the basis of a structured clinical interview and a physical and neurologic examination. The design of the study, selection and sampling procedures for ASPS participants, and a detailed description of the assessment of risk factors within the setting of the ASPS have been given elsewhere.25,26
Magnetic Resonance Imaging
MRI of the brain was performed with 1.5-T scanners (Siemens Symphony, Siemens Erlangen, Germany; Philips Gyroscan NT and Gyroscan ACS, Philips, Eindhoven, the Netherlands). Patients underwent scanning according to a standard protocol used for the workup of patients with suspected stroke at our clinic. This included an axial T2-weighted spin-echo sequence (repetition time/echo time [TR/TE]=2700 ms/120 ms), an axial fluid-attenuated inversion recovery sequence (TR/TE/inversion time=6000 ms/130 ms/1900 ms), a sagittal T1-weighted spin-echo sequence (TR/TE=612 ms/13 ms), and a diffusion-weighted, single-shot echo-planar imaging sequence (TR/TE=4600 ms/80 ms, isotropic diffusion weighting, b value=0 and 1000 s/mm2, field of view=250 mm, matrix=128x128, 2 averages) with 20 axial slices (thickness=5.0 mm, slice gap=1 mm). Apparent diffusion coefficient (ADC) maps were calculated from the reference scan (b=0) and the diffusion-weighted scan. The time lag between clinical onset of TGA and imaging was 0 to 24 hours in 10 patients (11.6%), >24 but <48 hours in 20 patients (23.3%), >48 but <115 hours in 36 patients (41.9%), and
115 hours in 20 patients (23.3%). The MRI protocol for the control subjects included a dual-echo spin-echo sequence (TR/TE=2000 to 2500 ms/30 and 90 ms) in axial orientation and a sagittal T1-weighted spin-echo sequence (TR/TE=600 ms/30 ms). The ASPS MRI protocol did not include DWI.
Rating of Scans
All scans were rated by consensus by 2 blinded experts (T.F., K.P.) for the presence of lesions with focal restriction of diffusivity (DWI+) of >3-mm diameter (which had to be confirmed by a concomitant ADC reduction; Figure 1) and for clinically silent ischemic infarcts and lacunes (defined as focal lesions involving the basal ganglia, the internal capsule, the thalamus, or the brain stem and not exceeding a maximum diameter of 10 mm). According to our scheme, white-matter hyperintensities (WMHs) were rated by 2 blinded experts (E.C., S.R.) as described previously27 as absent (grade 0), punctate (grade 1), early confluent (grade 2), and confluent (grade 3).
|
Plotting of DWI Lesions
To visualize both the topographic distribution and overlap of DWI+ lesions in the TGA cohort, all DWI+ lesions were plotted into standard space (MNI 152 averaged standard brain). First, DWI lesions were outlined manually in a magnified view of the diffusion-weighted images, and corresponding lesion masks were produced. These masks then were transferred into standard space by using the transformation matrix that was defined by prior registration of the individual diffusion-weighted scans to standard space. Registration was done with an affine 12-parameter model with a correlation ratio-based cost function and trilinear interpolation (FLIRT, part of the FMRIB software library FSL; available at www.fsl.ox.ac.uk). A probabilistic map for lesion occupancy was produced by calculating the relative frequency from all registered masks.
Statistical Analyses
The Statistical Package for the Social Sciences (PC+, version 14.01; SPSS Inc, Chicago, Ill) was used for data analysis. Categorical variables were tested by Pearsons
2 test or by 2x2 Fishers exact test in case of contingency tables containing <5 cases. Fulfilment of or deviation from normal distribution of continuous variables was tested by Kolmogorov-Smirnov statistics with a significance level after Lilliefors and additional inspection of histograms. Normally distributed continuous variables were compared with Student t test or 1-way ANOVA. The Mann-Whitney U test and the Kruskal-Wallis test were used as analog nonparametric tests. Spearmans rank correlation coefficients were calculated. The level of significance was set at 0.05 in all cases. Data are quoted as mean±SD unless otherwise stated.
| Results |
|---|
|
|
|---|
48 hours (n=6/56, 10.7%; P=0.7). The duration of the TGA episode also did not differ significantly between the DWI+ and the DWI– patient groups (DWI+, 4.8±3.3 hours vs DWI–, 6.2±5.7 hours; P=0.54).
|
|
Markers of cerebral small-vessel disease such as early confluent or confluent WMHs were seen in one third of TGA subjects (Table 2). Thirteen TGA patients (15.1%) showed cerebral lacunes. Clinically silent territorial infarcts were observed in 2 DWI– patients, 1 in the area of the posterior cerebral artery and 1 in the cerebellum. Regarding the distribution and frequency of WMHs, lacunes, and clinically silent infarcts, no significant differences were found between DWI+ and DWI– TGA subjects or between the entire TGA group and matched controls (n=92).
|
Cerebrovascular Risk Factors and Other Evidence for a CVD
The cerebrovascular risk factor profiles between DWI+TGA subjects and DWI– subjects did not show significant differences. As shown in Table 1, TGA patients with DWI abnormalities had a similar frequency of arterial hypertension and demonstrated similar mean values for systolic and diastolic blood pressures and for total cholesterol, HDL, LDL, and triglyceride levels than those without DWI lesions, and there were also no differences in comparison to the control population. None of the 6 subjects with diabetes mellitus and none of the 2 subjects with atrial fibrillation was in the DWI+ group. In the entire TGA cohort, the degree of atherosclerosis of the extracranial cerebral vessels assessed by sonography in general was low (92% of subjects either showed a normal finding or had only a mild stenosis). All 7 patients with higher grades of carotid artery stenosis (>30%) were in the DWI– group. Cardiac abnormalities as evidenced by echocardiography were also infrequent in TGA patients and, if present, mild. Cases with more severe changes of the heart valves (an 83-year-old woman with mitral insufficiency III and 1 56-year-old man with a mitral stenosis of 1 cm2 orifice area) or a patent foramen ovale (n=4) were found in the DWI– group.
As shown in Table 1, the distribution and frequency of cerebrovascular risk factors within the entire cohort of TGA patients were not significantly different from an age- and sex-matched population-based sample of normal elderly individuals. With regard to some factors like diastolic blood pressure, serum cholesterol, and HDL levels, the TGA cohort even demonstrated a more favorable risk profile. Furthermore, the proportion of subject with no or only minor cardiac abnormalities was similar between TGA patients (95.5%) and normal individuals (96.6%). Carotid artery abnormalities were more frequent in TGA patients compared with normal individuals, but this difference was driven by the 6 TGA subjects with moderate stenosis.
| Discussion |
|---|
|
|
|---|
The presence of infarctlike abnormalities on DWI in some patients with TGA10–19 has revived the discussion regarding a cerebrovascular etiology for such abnormalities in at least some individuals. Along these lines, a higher prevalence of atherosclerosis, as indicated by a higher intima-media thickness and substantial vascular risk factors in DWI+ patients, has been reported.12 This would imply the need for an extensive vascular workup and long-term therapeutic strategies as indicated for the secondary prevention of stroke. Whereas avoidance of and correction for vascular risk factors are certainly appropriate in any individual, our data do not suggest a specific preponderance of cerebrovascular disorders, neither in the entire group of TGA patients nor in those with a DWI lesion, when compared with community-based controls. There was no evidence for an increased rate or intensity of cerebrovascular risk factors, and there was no indirect evidence for an increased rate of microangiopathy, as indicated by higher grades of WMHs and lacunes. Early confluent and confluent WMHs have been associated with microangiopathy,29 and their prevalence was similar in TGA subgroups as well as in comparison with ASPS participants. Other diagnostic workup procedures, including ECG, extracranial duplex sonography, and echocardiography, also did not provide more direct evidence for a cerebrovascular etiology.
This retrospective analysis showed acute DWI lesions in only 11% of individuals with TGA. This is relatively low compared with some previous reports.10–13 In a review of existing MRI studies on acute TGA, 52 of the published 99 patients had DWI abnormalities, corresponding to a rate of DWI positivity of 52%.3 In a careful serial study, a frequency of DWI lesions of even 84% was observed.10 This suggests that higher rates of lesion detection might be achieved with repeated scanning at later time intervals, dedicated protocols, or higher field strengths. As a consequence, it could be argued that in our study, some individuals might have been falsely labeled as DWI–, and this might have obscured the comparison between TGA subgroups. Although this cannot be ruled out, our main conclusions are supported by the fact that even those patients who were definitely DWI+ did not show any difference in regard to cerebrovascular risk factors or MRI findings suggestive of small-vessel disease when compared with population-based controls. It has also been speculated that the incongruence between imaging findings could be explained by the delayed detectability of DWI lesions in TGA compared with stroke.10 In this context, it is interesting that in our study, DWI– and DWI+ TGA patients did not show significant differences in the interval between the onset of TGA and MRI scanning, and there were also no significant differences in the rate of lesion detection between subjects scanned within or beyond 48 hours in this study. Differences in the timing of scanning therefore cannot be regarded as the sole explanation for the low rate of DWI+ lesions in the present study.
Although our results strongly argue against an association between CVD and TGA, the true etiology of DWI+ lesions in the context of TGA still remains speculative. Interestingly and in line with previous studies (for a review, see Sander and Sander3), mapping of lesions consistently pointed to the involvement of the same brain regions relevant to memory function, with a predominance for the left hemisphere. Because the hippocampal artery supplies an internal anastomosis between an upper and a lower artery, some have suggested this to be a particularly hypoxia-susceptible watershed area (the so-called sector of Sommer).30 The similarity between DWI abnormalities in TGA and areas of acute ischemia is intriguing, but the consistency of lesion size and the absence of other DWI lesions argue against ischemic infarction per se. In this context, it is particularly interesting that the few existing longitudinal studies also did not document persistent abnormal signal changes in the hippocampus after TGA, which would have been compatible with postischemic structural damage.11,14 Indeed, in addition to cerebral ischemia, ADC reductions have also been observed after cortical spreading depression, ischemic depolarizations, status epilepticus, and hypoglycemia.31–35 A DWI lesion thus has to be considered a nonspecific finding with several possible underlying mechanisms, probably all leading to focal energy failure. Recently, a combined study with single-photon emission computed tomography and transcranial magnetic stimulation suggested a relation between hypoperfusion in several brain areas (in the thalami, and also in the temporal lobes in a subset of patients) and reduced activity in inhibitory circuits.36 Conceptually, studies in TGA patients would thus appear to benefit from a combination of DWI with perfusion-weighted MRI, but to date, this approach has been used only in a case study, which yielded negative results.37 Unfortunately, both the design of our study and the small numbers of migraneurs and subjects with pathologic EEG findings prohibit us from drawing further conclusions on some of these alternative hypotheses. Clearly, pathophysiologic mechanisms other than focal ischemia from CVD need to be explored further as causes of a temporal dysfunction in memory-relevant structures, as indicated by more recent reports on hemodynamic disturbances in venous flow patterns in TGA.38–40
| Acknowledgments |
|---|
Disclosures
None.
| Footnotes |
|---|
The first 2 authors contributed equally to this work.
Received October 29, 2007; revision received December 14, 2007; accepted January 8, 2008.
| References |
|---|
|
|
|---|
2. Hodges JR, Oxbury SM. Persistent memory impairment following transient global amnesia. J Clin Exp Neuropsychol. 1990; 12: 904–920.[Medline] [Order article via Infotrieve]
3. Sander K, Sander D. New insights into transient global amnesia: recent imaging and clinical findings. Lancet Neurol. 2005; 4: 437–444.[CrossRef][Medline] [Order article via Infotrieve]
4. Pantoni L, Lamassa M, Inzitari D. Transient global amnesia: a review emphasizing pathogenic aspects. Acta Neurol Scand. 2000; 102: 275–283.[CrossRef][Medline] [Order article via Infotrieve]
5. Quinette P, Guillery-Girard B, Dayan J, de la Sayette V, Marquis S, Viader F, Desgranges B, Eustache F. What does transient global amnesia really mean? review of the literature and thorough study of 142 cases. Brain. 2006; 129: 1640–1658.
6. Fisher CM, Adams R. Transient global amnesia. Trans Am Neurol Assoc. 1958; 83: 143–146.
7. Gass A, Ay H, Szabo K, Koroshetz WJ. Diffusion-weighted MRI for the small stuff: the details of acute cerebral ischaemia. Lancet Neurol. 2004; 3: 39–45.[CrossRef][Medline] [Order article via Infotrieve]
8. Fisher M, Albers GW. Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke. Neurology. 1999; 52: 1750–1756.
9. Tong DC, Grossman M. What causes transient global amnesia?: new insights from DWI. Neurology. 2004; 62: 2154–2155.
10. Sedlaczek O, Hirsch JG, Grips E, Peters CNA, Gass A, Wohrle J, Hennerici M. Detection of delayed focal MR changes in the lateral hippocampus in transient global amnesia. Neurology. 2004; 62: 2165–2170.
11. Bartsch T, Alfke K, Stingele R, Rohr A, Freitag-Wolf S, Jansen O, Deuschl G. Selective affection of hippocampal CA-1 neurons in patients with transient global amnesia without long-term sequelae. Brain. 2006; 129: 2874–2884.
12. Winbeck K, Etgen T, von Einsiedel HG, Rottinger M, Sander D. DWI in transient global amnesia and TIA: proposal for an ischaemic origin of TGA. J Neurol Neurosurg Psychiatry. 2005; 76: 438–441.
13. Lee HY, Kim JH, Weon YC, Lee JS, Kim SY, Youn SW, Kim SH. Diffusion-weighted imaging in transient global amnesia exposes the CA1 region of the hippocampus. Neuroradiology. 2007; 49: 481–487.[CrossRef][Medline] [Order article via Infotrieve]
14. Cianfoni A, Tartaglione T, Gaudino S, Pilato F, Saturno E, Tonali PA, Di Lazzaro V. Hippocampal magnetic resonance imaging abnormalities in transient global amnesia. Arch Neurol. 2005; 62: 1468–1469.
15. Felix MM, Castro LH, Maia AC Jr, da Rocha AJ. Evidence of acute ischemic tissue change in transient global amnesia in magnetic resonance imaging: case report and literature review. J Neuroimaging. 2005; 15: 203–205.[CrossRef][Medline] [Order article via Infotrieve]
16. Ay H, Furie KL, Yamada K, Koroshetz WJ. Diffusion-weighted MRI characterizes the ischemic lesion in transient global amnesia. Neurology. 1998; 51: 901–903.
17. Matsui M, Imamura T, Sakamoto S, Ishii K, Kazui H, Mori E. Transient global amnesia: increased signal intensity in the right hippocampus on diffusion-weighted magnetic resonance imaging. Neuroradiology. 2002; 44: 235–238.[CrossRef][Medline] [Order article via Infotrieve]
18. Jeong Y, Kim GM, Min Song Y, Na DL. A tiny hippocampal ischemic lesion associated with transient global amnesia. Cerebrovasc Dis. 2003; 16: 439–442.[CrossRef][Medline] [Order article via Infotrieve]
19. Di Filippo M, Calabresi P. Ischemic bilateral hippocampal dysfunction during transient global amnesia. Neurology. 2007; 69: 493.
20. Zorzon M, Antonutti L, Mase G, Biasutti E, Vitrani B, Cazzato G. Transient global amnesia and transient ischemic attack: natural history, vascular risk factors, and associated conditions. Stroke. 1995; 26: 1536–1542.
21. Pantoni L, Bertini E, Lamassa M, Pracucci G, Inzitari D. Clinical features, risk factors, and prognosis in transient global amnesia: a follow-up study. Eur J Neurol. 2005; 12: 350–356.[CrossRef][Medline] [Order article via Infotrieve]
22. Huber R, Aschoff AJ, Ludolph AC, Riepe MW. Transient global amnesia. J Neurol. 2002; 249: 15–20.
23. Greer DM, Schaefer PW, Schwamm LH. Unilateral temporal lobe stroke causing ischemic transient global amnesia: role for diffusion-weighted imaging in the initial evaluation. J Neuroimaging. 2001; 11: 317–319.[Medline] [Order article via Infotrieve]
24. Gass A, Gaa J, Hirsch J, Schwartz A, Hennerici MG. Lack of evidence of acute ischemic tissue change in transient global amnesia on single-shot echo-planar diffusion-weighted MRI. Stroke. 1999; 30: 2070–2072.
25. Schmidt R, Fazekas F, Kapeller P, Schmidt H, Hartung HP. MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology. 1999; 53: 132–139.
26. Enzinger C, Fazekas F, Matthews PM, Ropele S, Schmidt H, Smith S, Schmidt R. Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology. 2005; 64: 1704–1711.
27. Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F, the Austrian Stroke Prevention Study. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet. 2003; 14: 2046–2048.
28. Duvernoy H. The Human Brain: Surface, Three-Dimensional Sectional Anatomy With MRI, and Blood Supply. Vienna/New York: Springer-Verlag; 1999.
29. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993; 43: 1683–1689.
30. Erdem A, Yasargil G, Roth P. Microsurgical anatomy of the hippocampal arteries. J Neurosurg. 1993; 79: 256–265.[Medline] [Order article via Infotrieve]
31. Sotak CH. Nuclear magnetic resonance (NMR) measurement of the apparent diffusion coefficient (ADC) of tissue water and its relationship to cell volume changes in pathological states. Neurochem Int. 2004; 45: 569–582.[CrossRef][Medline] [Order article via Infotrieve]
32. Smith JM, Bradley DP, James MF, Huang CLH. Physiological studies of cortical spreading depression. Biol Rev. 2006; 81: 457–481.[Medline] [Order article via Infotrieve]
33. Miyasaka N, Nagaoka T, Kuroiwa T, Akimoto H, Haku T, Kubota T, Aso T. Histopathologic correlates of temporal diffusion changes in a rat model of cerebral hypoxia/ischemia. AJNR Am J Neuroradiol. 2000; 21: 60–66.
34. Hasegawa Y, Formato JE, Latour LL, Gutierrez JA, Liu K-F, Garcia JH, Sotak CH, Fisher M, Brayden JE. Severe transient hypoglycemia causes reversible change in the apparent diffusion coefficient of water. Stroke. 1996; 27: 1648–1656.
35. Szabo K, Poepel A, Pohlmann-Eden B, Hirsch J, Back T, Sedlaczek O, Hennerici M, Gass A. Diffusion-weighted and perfusion MRI demonstrates parenchymal changes in complex partial status epilepticus. Brain. 2005; 128: 1369–1376.
36. Nardone R, Buffone EC, Matullo MF, Tezzon F. Motor cortex excitability in transient global amnesia. J Neurol. 2004; 251: 42–46.[CrossRef][Medline] [Order article via Infotrieve]
37. Budson AE, Schlaug G, Briemberg HR, Furie KL, Ay H. Perfusion- and diffusion-weighted magnetic resonance imaging in transient global amnesia. Neurology. 1999; 53: 239.
38. Chung CP, Hsu HY, Chao AC, Chang FC, Sheng WY, Hu HH. Detection of intracranial venous reflux in patients of transient global amnesia. Neurology. 2006; 66: 1873–1877.
39. Sander D, Winbeck K, Etgen T, Knapp R, Klingelhofer J, Conrad B. Disturbance of venous flow patterns in patients with transient global amnesia. Lancet. 2000; 356: 1982–1984.[CrossRef][Medline] [Order article via Infotrieve]
40. Schreiber SJ, Doepp F, Klingebiel R, Valdueza JM. Internal jugular vein valve incompetence and intracranial venous anatomy in transient global amnesia. J Neurol Neurosurg Psychiatry. 2005; 76: 509–513.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |